In estrogen receptor alpha (ERα)-positive breast cancer cells, BRD4 is a master activator of ERα-occupied super-enhancers and the transcription of ERα target genes, such as RET which in turn activates ERα phosphorylation and ERα target gene expression. Here, ESR1 is linked to breast carcinoma.